BLACK FRIDAY DEAL|Save 70% on a Vantage subscription today!Buy Now
|Login
Ground News Logo
Dec 05, 2021SUBSCRIBE NOW

FDA panel recommends Pfizer’s low-dose Covid vaccine for kids ages 5 to 11

A key Food and Drug Administration advisory committee on Tuesday recommended a lower dose of Pfizer and BioNTech’s Covid-19 vaccine for children ages 5 to 11, a critical step in getting some 28 million more kids in the U.S. protected against the virus as the delta variant spreads.
1 month ago|Washington, United States

BIAS COVERAGE DISTRIBUTION

123 of these news sources are bias rated
62 are CENTER
L 27%
C 50%
R 23%
HuffPost
Common Dreams
CBC News
The Hindu
NDTV
CBS Local
+28
Reuters
CTV News
NZ Herald
CNBC
+59
Washington Times
Independent.ie
The Telegraph
Financial Post
+17
Daily Express
Washington Examiner
The Daily Wire
National Review
+3
The Gateway Pundit
WND
ALL ARTICLES
Yahoo News
Yahoo News

FDA advisers back Pfizer’s COVID-19 vaccine for young kids

A panel of U.S. health advisers on Tuesday endorsed kid-size doses of Pfizer's COVID-19 vaccine, moving the U.S. closer to beginning vaccinations in children ages 5 to 11. A Food and Drug Administration advisory panel voted unanimously with one abstention that the vaccine's benefits in preventing COVID-19 in that age group outweigh any potential risks — including a heart-related side effect that's been very rare in teens and young adults who get…

1 month ago|Los Angeles, United States
CBC News
CBC NewsL

FDA advisory committee recommends authorizing Pfizer's COVID vaccine for kids

The U.S. Food and Drug Administration isn't bound by the committee's recommendation, but is expected to consider it and make a decision in the coming days on whether to approve the vaccine for kids five to 11 years old.

1 month ago|Canada
Reuters
ReutersC

U.S. FDA advisers back Pfizer/BioNTech COVID-19 vaccine for children

An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech SE COVID-19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks.

1 month ago|United Kingdom
News18 India
News18 India

U.S. FDA Advisers Back Pfizer/BioNTech COVID-19 Vaccine For Children

An expert panel on Tuesday voted overwhelmingly to recommend the U.S. Food and Drug Administration authorize the Pfizer Inc and BioNTech SE COVID19 vaccine for children ages 5 to 11, saying the benefits of inoculation outweigh the risks.

1 month ago|India
CTV News
CTV NewsC

U.S. FDA advisers back Pfizer's COVID-19 vaccine for young kids

The U.S. moved a step closer to expanding COVID-19 vaccinations for millions more children as government advisers on Tuesday endorsed kid-size doses of Pfizer's shots for 5- to 11-year-olds.

1 month ago|Toronto, Canada
The Hindu
The Hindu L

U.S. FDA panel backs Pfizer’s low-dose COVID-19 vaccine for children

A Food and Drug Administration advisory panel voted unanimously, that the vaccine’s benefits in preventing COVID-19 in the 5-11 age group outweigh any potential risks.

1 month ago|India
NDTV
NDTVL

US Panel Recommends Pfizer Covid Vaccine For Younger Children

A medical panel of US government advisors endorsed the Pfizer Covid-19 vaccine in five-to-11-year-olds Tuesday, paving the way for younger children to get their shots within weeks.

1 month ago|New Delhi, India
CBS Local
CBS LocalL

FDA Advisers Back Pfizer's COVID-19 Vaccine for Kids 5 to 11 Years Old

WASHINGTON (CBS NEWS) — Pfizer’s request to roll out COVID-19 vaccines for Americans as young as 5 years old cleared a key regulatory hurdle Tuesday, after a panel of the Food and Drug Administration’s outside vaccine advisers voted by a majority to back Pfizer’s request. The vote is a crucial step towards vaccinations for younger children, but not the final word. If the FDA decides to formally authorize the vaccine, the Centers for Disease Cont…

1 month ago|United States
USA Today
USA TodayL

FDA committee moves Pfizer-BioNTech COVID-19 vaccine closer to use for children ages 5-11

In children ages 5-11, the Pfizer-BioNTech vaccine was more than 90% protective against contracting symptomatic COVID-19, according to company data.

1 month ago|United States
Washington Times
Washington TimesR

FDA panel recommends COVID-19 vaccine for ages 5-11

A key advisory panel on Tuesday recommended the Pfizer-BioNTech COVID-19 shots for emergency use in children ages 5 to 11, setting the stage for shots to become available to 28 million children by early November and fueling debate over the risks and rewards of vaccinating an age group that’s accounted for 0.01% of COVID-19 deaths in America.

1 month ago|Washington, United States
COVERAGE DETAILS

BIAS COVERAGE DISTRIBUTION

123 of these news sources are bias rated
62 are CENTER
L 27%
C 50%
R 23%
HuffPost
Common Dreams
CBC News
The Hindu
NDTV
CBS Local
USA Today
The Independent
abc News
Sydney Morning Herald
CBS News
South China Morning Post
The Washington Post
+21
Reuters
CTV News
NZ Herald
CNBC
Associated Press News
IBTimes
RTÉ
The Hill
Channel News Asia
c|net
VOA News
+52
Washington Times
Independent.ie
The Telegraph
Financial Post
Russia Today
National Post
MY Northwest
Pioneer Press
News
Nikkei
Las Vegas Review-Journal
+10
Daily Express
Washington Examiner
The Daily Wire
National Review
Sky News Australia
CBN
The Gateway Pundit
WND
Total News Sources173Leaning Left33 sourcesLeaning Right28 sourcesCenter62 sourcesLast Updated1 month ago
0
TOPICS
SIMILAR STORIES